Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Healthy Participants 1

Interventions

Cyclophosphamide 34 Doxorubicin 24 fludarabine phosphate 20 Vinblastine 20 Nivolumab 20 Dacarbazine 20 Brentuximab Vedotin 20 pembrolizumab 19 fludarabine 18 Mycophenolic Acid 17 Whole-Body Irradiation 15 Etoposide 14 Filgrastim 13 Melphalan 12 Granulocyte Colony-Stimulating Factor 10 Gemcitabine 10 Bleomycin 10 Tacrolimus 9 Radiotherapy 9 Prednisone 9 Peripheral Blood Stem Cell Transplantation 9 Busulfan 9 Specimen Handling 8 Vincristine 7 Sirolimus 7 Magnetic Resonance Spectroscopy 7 Cyclosporine 7 pegfilgrastim 6 Stem Cell Transplantation 6 Bendamustine Hydrochloride 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Dextromethorphan × 1 year × Clear all

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡